Zura Bio Ltd [NASDAQ: ZURA] traded at a high on Thursday, posting a 1.73 gain after which it closed the day’ session at $1.76.
The results of the trading session contributed to over 3394666 shares changing hands. Over the past one week, the price volatility of Zura Bio Ltd stands at 8.68% while the volatility over the past one month is 8.74%.
The market cap for ZURA stock reached $114.92 million, with 65.29 million shares outstanding and 47.09 million shares in the current float. Compared to the average trading volume of 478.55K shares, ZURA reached a trading volume of 3394666 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Zura Bio Ltd [ZURA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZURA shares is $14.29 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZURA stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Zura Bio Ltd shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on November 04, 2024. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Neutral. The new note on the price target was released on September 05, 2024, representing the official price target for Zura Bio Ltd stock. Previously, the target price had yet another raise to $26, while Piper Sandler analysts kept a Overweight rating on ZURA stock.
The Average True Range (ATR) for Zura Bio Ltd is set at 0.19 The Price to Book ratio for the last quarter was 0.75, with the Price to Cash per share for the same quarter was set at 2.88.
How has ZURA stock performed recently?
Zura Bio Ltd [ZURA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.33. With this latest performance, ZURA shares dropped by -29.60% in over the last four-week period, additionally sinking by -52.82% over the last 6 months – not to mention a drop of -47.15% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZURA stock in for the last two-week period is set at 35.50, with the RSI for the last a single of trading hit 37.30, and the three-weeks RSI is set at 35.82 for Zura Bio Ltd [ZURA]. The present Moving Average for the last 50 days of trading for this stock 2.4163, while it was recorded at 1.6960 for the last single week of trading, and 3.6620 for the last 200 days.
Zura Bio Ltd [ZURA]: Deeper insight into the fundamentals
Zura Bio Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.36 and a Current Ratio set at 10.36.
Earnings analysis for Zura Bio Ltd [ZURA]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZURA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Zura Bio Ltd go to 24.30%.
Insider trade positions for Zura Bio Ltd [ZURA]
There are presently around $58.04%, or 79.86%% of ZURA stock, in the hands of institutional investors.
